Securing U.S. Innovation Leadership on Behalf of Patients

Patients are in urgent need of breakthrough treatments, and the global community benefits most when America drives the next generation of biotechnology innovations. However, America’s leadership is increasingly challenged. This session convenes leading voices from industry, government, and the nonprofit sector to examine the evolving competitive landscape, assess vulnerabilities across the U.S. biotechnology ecosystem, discuss success stories such as ARPA-H, and outline strategies to strengthen domestic innovation and manufacturing capacity. Panelists will explore actionable solutions essential to ensuring that American biotechnology leadership - and the patient impact it enables - endures for decades to come.